Medifirst Solutions to Update Shareholders on Corporate and Sales Strategy


FREEHOLD, NJ--(Marketwired - Jul 26, 2016) - MEDIFIRST SOLUTIONS, INC. (OTC PINK: MFST) (the "Company" or "Medifirst") would like to update shareholders regarding its new stage of operations. As recently announced, Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission, received clearance from the U.S. Food and Drug Administration ("FDA") to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.

As part of the pre-sales and marketing rollout of the Laser Series, Medifirst has begun to implement internal controls and procedures as mandated by the FDA. These controls and procedures include in-office checks and balances, as well as those required at its manufacturer, and must be implemented prior to initiating sales. The Company is aggressively putting together a sales & distribution team to offer its lasers in the US market. The team will be made up of seasoned professionals with experience in the sales and marketing of medical devices that will initially focus on targeting and analyzing the specific markets and sectors to which to market its products. Additionally, as part of a corporate restructure the company will be appointing Board Members with well-established credentials in the medical device Industry as well as established and renowned industry professionals from the business and financial community. Medifirst has plans to add a CFO and additional officers to its corporate operations. These announcements are forthcoming.

Commented President Bruce J. Schoengood, "The reaction to our FDA clearance has simply been overwhelming. We are aggressively working to ramp up operations and meet all FDA requirements. We have been contacted by healthcare professionals regarding sales, which will be implemented after FDA compliance is complete. I am also pleased that we will be adding many industry leaders to our Board of Directors, as well as adding to our advisory board. This is a very exciting time and we appreciate the continued support of our shareholders."

About the Infrared Laser

The Time Machine Series Lasers Model TTML-8102000 - 810/830 nm is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions.

About Medifirst Solutions, Inc.

Medifirst Solutions, Inc. is a Nevada corporation that is headquartered in New Jersey. The company seeks innovative medical and healthcare products and technologies which are targeted to both medical and healthcare professionals, as well as everyday consumers. Medifirst is developing and establishing both consumer and professional medical cliental that can serve as a pipeline that will allow for distribution of future products and services. For more details visit www.medifirstsolutions.com for more information.

Forward-Looking Statements: The statements in this press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward-looking statements.

Contact Information:

Medifirst Solutions, Inc.
Investor Relations
(732) 786-8044
info@medifirstsolutions.com
www.medifirstsolutions.com